247 related articles for article (PubMed ID: 20107878)
1. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity.
Chen XQ; Yu YC; Deng HH; Sun JZ; Dai Z; Wu YW; Yang M
J Clin Immunol; 2010 Mar; 30(2):221-5. PubMed ID: 20107878
[TBL] [Abstract][Full Text] [Related]
2. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
Chen M; Chen X; Wan Q
Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
[TBL] [Abstract][Full Text] [Related]
3. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
[TBL] [Abstract][Full Text] [Related]
4. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
5. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
6. Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
Qi ZX; Wang LY; Fan YC; Zhang JJ; Li T; Wang K
J Viral Hepat; 2012 Nov; 19(11):811-22. PubMed ID: 23043388
[TBL] [Abstract][Full Text] [Related]
7. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
8. T helper 17 cell population in lupus erythematosus.
Bălănescu P; Bălănescu E; Tănăsescu C; Nicolau A; Tănăsescu R; Grancea C; Vagu C; Ruţă S; Bleoţu C
Rom J Intern Med; 2010; 48(3):255-9. PubMed ID: 21528751
[TBL] [Abstract][Full Text] [Related]
9. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.
Wong CK; Lit LC; Tam LS; Li EK; Wong PT; Lam CW
Clin Immunol; 2008 Jun; 127(3):385-93. PubMed ID: 18373953
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
11. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
12. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
AlFadhli S; AlFailakawi A; Ghanem AA
Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
Pasha HF; Tantawy EA; Youssef MA
Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
[TBL] [Abstract][Full Text] [Related]
14. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
15. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of CCR6
Zhong W; Jiang Y; Ma H; Wu J; Jiang Z; Zhao L
Sci Rep; 2017 Oct; 7(1):12962. PubMed ID: 29021537
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
18. Low level of serum interleukin 27 in patients with systemic lupus erythematosus.
Li TT; Zhang T; Chen GM; Zhu QQ; Tao JH; Pan HF; Ye DQ
J Investig Med; 2010 Jun; 58(5):737-9. PubMed ID: 20216231
[TBL] [Abstract][Full Text] [Related]
19. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
20. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis.
Shi Y; Wang H; Su Z; Chen J; Xue Y; Wang S; Xue Y; He Z; Yang H; Zhou C; Kong F; Liu Y; Yang P; Lu L; Shao Q; Huang X; Xu H
Scand J Immunol; 2010 Sep; 72(3):250-5. PubMed ID: 20696023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
